Latest DEF 14A proxy statements

Artelo Biosciences schedules its 2026 Annual Meeting for July 17, 2026, to elect directors and seek approval to triple authorized common stock.

Curis, Inc. has scheduled a special meeting for June 25, 2026, to seek shareholder approval for a reverse stock split ranging from 1-for-5 to 1-for-25.

DXC Technology's 2026 Proxy Statement outlines director elections, executive compensation, and proposals to extend and increase share reserves for incentive plans.

Radnostix Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, detailing proposals for director elections, auditor ratification, and an incentive plan.

BayFirst Financial Corp. is holding a special meeting on July 14, 2026, to seek shareholder approval for proposals related to its recent $80 million capital raise, including the conversion of preferred stock and an increase in authorized shares.

Ennis, Inc. is holding its 2026 Annual Meeting of Shareholders on July 16, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Decoy Therapeutics Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 14, 2026, to elect directors, vote on executive compensation, and ratify auditor appointment.

Advanced Biomed Inc. has filed its proxy statement for the Annual Meeting of Stockholders on June 30, 2026, detailing proposals including director elections, executive compensation votes, and auditor ratification.

Amesite Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on July 13, 2026.

Laser Photonics Corporation is holding a special shareholder meeting on June 26, 2026, to vote on two warrant inducement agreements that have provided significant capital.

Daxor Corporation has issued its proxy statement for the Annual Meeting of Stockholders scheduled for June 23, 2026, detailing proposals for director elections and auditor ratification.

Health Catalyst, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 16, 2026, to be held virtually.

BioAtla, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 16, 2026, to be held virtually, with key proposals including director elections and executive compensation.

Entera Bio Ltd. announced its 2026 Annual Meeting of Shareholders, set for July 14, 2026, to vote on director elections, executive and non-executive director compensation, and amendments to equity plans and articles of association.

Cirrus Logic, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on July 31, 2026, to vote on director elections, auditor ratification, executive compensation, and an updated incentive plan.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.